242 related articles for article (PubMed ID: 27390013)
1. Clinical feasibility of dried blood spots: Analytics, validation, and applications.
Enderle Y; Foerster K; Burhenne J
J Pharm Biomed Anal; 2016 Oct; 130():231-243. PubMed ID: 27390013
[TBL] [Abstract][Full Text] [Related]
2. Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring.
Capiau S; Veenhof H; Koster RA; Bergqvist Y; Boettcher M; Halmingh O; Keevil BG; Koch BCP; Linden R; Pistos C; Stolk LM; Touw DJ; Stove CP; Alffenaar JC
Ther Drug Monit; 2019 Aug; 41(4):409-430. PubMed ID: 31268966
[TBL] [Abstract][Full Text] [Related]
3. Dried blood spots: concepts, present status, and future perspectives in bioanalysis.
Sharma A; Jaiswal S; Shukla M; Lal J
Drug Test Anal; 2014 May; 6(5):399-414. PubMed ID: 24692095
[TBL] [Abstract][Full Text] [Related]
4. Quality Assessment of Dried Blood Spots from Patients With Tuberculosis from 4 Countries.
Zuur MA; Veenhof H; Aleksa A; Vanʼt Boveneind-Vrubleuskaya N; Darmawan E; Hasnain MG; Heysell SK; Jongedijk EM; Koster RA; Magis-Escurra C; Martinez N; Molinas G; Mondal D; Mulyani UA; Perwitasari DA; Tsivunchyk A; Touw DJ; Alffenaar JC
Ther Drug Monit; 2019 Dec; 41(6):714-718. PubMed ID: 31169760
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting.
Knapen LM; Beer Y; Brüggemann RJM; Stolk LM; Vries F; Tjan-Heijnen VCG; Erp NPV; Croes S
J Pharm Biomed Anal; 2018 Feb; 149():106-113. PubMed ID: 29112898
[TBL] [Abstract][Full Text] [Related]
6. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.
Li Y; Henion J; Abbott R; Wang P
Bioanalysis; 2011 Nov; 3(22):2501-14. PubMed ID: 22122599
[TBL] [Abstract][Full Text] [Related]
7. Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review.
Jager NG; Rosing H; Schellens JH; Beijnen JH
Bioanalysis; 2014 Sep; 6(18):2481-514. PubMed ID: 25384597
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Analytical and Clinical Concordance of 25-Hydroxyvitamin D Levels in Dried Blood Spots, Dried Serum Spots, and Serum as Potential Biorepository Specimens.
Karvaly G; Molnár-Világos G; Kovács K; Mészáros K; Patócs A; Vásárhelyi B
Biopreserv Biobank; 2017 Aug; 15(4):285-292. PubMed ID: 28157384
[TBL] [Abstract][Full Text] [Related]
9. Dried blood spots in toxicology: from the cradle to the grave?
Stove CP; Ingels AS; De Kesel PM; Lambert WE
Crit Rev Toxicol; 2012 Mar; 42(3):230-43. PubMed ID: 22348353
[TBL] [Abstract][Full Text] [Related]
10. Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium.
Timmerman P; White S; Cobb Z; de Vries R; Thomas E; van Baar B;
Bioanalysis; 2013 Sep; 5(17):2129-36. PubMed ID: 23829466
[TBL] [Abstract][Full Text] [Related]
11. EBF recommendation on the validation of bioanalytical methods for dried blood spots.
Timmerman P; White S; Globig S; Lüdtke S; Brunet L; Smeraglia J
Bioanalysis; 2011 Jul; 3(14):1567-75. PubMed ID: 21749218
[TBL] [Abstract][Full Text] [Related]
12. The effect of hematocrit on bioanalysis of DBS: results from the EBF DBS-microsampling consortium.
de Vries R; Barfield M; van de Merbel N; Schmid B; Siethoff C; Ortiz J; Verheij E; van Baar B; Cobb Z; White S; Timmerman P
Bioanalysis; 2013 Sep; 5(17):2147-60. PubMed ID: 23829463
[TBL] [Abstract][Full Text] [Related]
13. Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring.
Antunes MV; Charão MF; Linden R
Clin Biochem; 2016 Sep; 49(13-14):1035-46. PubMed ID: 27179588
[TBL] [Abstract][Full Text] [Related]
14. Ensuring the collection of high-quality dried blood spot samples across multisite clinical studies.
Panchal T; Spooner N; Barfield M
Bioanalysis; 2017 Jan; 9(2):209-213. PubMed ID: 27960550
[TBL] [Abstract][Full Text] [Related]
15. Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities.
Müller IR; Linden G; Charão MF; Antunes MV; Linden R
Expert Rev Clin Pharmacol; 2023; 16(8):691-701. PubMed ID: 37300458
[TBL] [Abstract][Full Text] [Related]
16. Dried blood spot analysis of gabapentin as a valid alternative for serum: a bridging study.
Sadones N; Van Bever E; Van Bortel L; Lambert WE; Stove CP
J Pharm Biomed Anal; 2017 Jan; 132():72-76. PubMed ID: 27697572
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring by dried blood spot: progress to date and future directions.
Wilhelm AJ; den Burger JC; Swart EL
Clin Pharmacokinet; 2014 Nov; 53(11):961-73. PubMed ID: 25204403
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring in dried blood spots using liquid microjunction surface sampling and high resolution mass spectrometry.
Gaissmaier T; Siebenhaar M; Todorova V; Hüllen V; Hopf C
Analyst; 2016 Feb; 141(3):892-901. PubMed ID: 26759833
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies.
Xu Y; Fang W; Zeng W; Leijen S; Woolf EJ
Anal Bioanal Chem; 2012 Dec; 404(10):3037-48. PubMed ID: 23099526
[TBL] [Abstract][Full Text] [Related]
20. IS addition in bioanalysis of DBS: results from the EBF DBS-microsampling consortium.
van Baar BL; Verhaeghe T; Heudi O; Rohde M; Wood S; Wieling J; de Vries R; White S; Cobb Z; Timmerman P
Bioanalysis; 2013 Sep; 5(17):2137-45. PubMed ID: 23829464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
